Patient-Reported Outcomes of COVID-19 Vaccine Breakthrough Infection-Associated Changes in Glucose Control in Subjects With Type 1 Diabetes (PRO-VACS 2 Study)

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes care 2023-01, Vol.46 (1), p.e8-e9
Hauptverfasser:	Dicembrini, Ilaria, Scoccimarro, Daniele, Del Vescovo, Gloria Giovanna, Marinelli, Christian, Zago, Elena, Delli Poggi, Chiara, Pala, Laura, Mannucci, Edoardo
Format:	Artikel
Sprache:	eng
Schlagworte:	Blood Glucose Breakthrough Infections Clinical outcomes COVID-19 - prevention & control COVID-19 vaccines COVID-19 Vaccines - therapeutic use Diabetes Diabetes mellitus Diabetes mellitus (insulin dependent) Diabetes Mellitus, Type 1 - complications Humans Infections Patient Reported Outcome Measures Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!